RN277
RN277 is an inhibitor for LRRK2 type II kinase. RN277 can be used as a cellular tool targeting the LRRK2 inactive state. RN277 can inhibit LRRK1 kinase activity in vitro. RN277 inhibits LRRK2 kinase activity in vitro (IC50 = 70 nM) . RN277 reduces phosphorylation of Rab8a dose-dependently. RN277 can be studied in research for Parkingson’s disease[1].
Product Specifications
UNSPSC
12352005
Target
LRRK2
Related Pathways
Autophagy
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
ClC1=NC(N2CCOCC2)=C(C(C3=CC=CC(NC(NC4=CC(C(C)(C)C)=NN4C5=CC=C(C)C=C5)=O)=C3)=CN6)C6=N1
Molecular Formula
C31H33ClN8O2
Molecular Weight
585.10
References & Citations
[1]Raig ND, et al., (2025) Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2. bioRxiv [Preprint]. 2025 Feb 13:2024.09.17.613365.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9394797 Inquire
Chicken Thioredoxin Domain-Containing Protein 17 (TXNDC17) ELISA Kit
Sign In for Pricing
View Details